Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts
- 30 September 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S66-S69
- https://doi.org/10.1016/s0959-8049(02)80605-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Rectum and AnusThe American Journal of Surgical Pathology, 2001
- STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implicationsOncogene, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- The histopathological differential diagnosis of gastrointestinal stromal tumoursJournal of Clinical Pathology, 2001
- Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Archiv, 2001
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Salvage surgery for patients with recurrent gastrointestinal sarcomaCancer, 2000
- Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or LeiomyosarcomasThe American Journal of Pathology, 1999